Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (8): 736-738.DOI: 10.3969/j.issn.1673-8640.2019.08.013
Previous Articles Next Articles
Received:
2018-10-07
Online:
2019-08-30
Published:
2019-08-27
CLC Number:
. [J]. Laboratory Medicine, 2019, 34(8): 736-738.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.08.013
牛奶sIgE分级 | 例数 | 总IgE(KU/L) |
---|---|---|
0级 | 93 | <2.3 |
Ⅰ级 | 12 | 4.80(4.30~8.98) |
Ⅱ级 | 17 | 11.10(6.45~23.80) |
Ⅲ级 | 5 | 41.50(15.75~53.55) |
Ⅳ级 | 1 | 216.0 |
Ⅴ级 | 1 | 212.0 |
牛奶sIgE分级 | 例数 | 总IgE(KU/L) |
---|---|---|
0级 | 93 | <2.3 |
Ⅰ级 | 12 | 4.80(4.30~8.98) |
Ⅱ级 | 17 | 11.10(6.45~23.80) |
Ⅲ级 | 5 | 41.50(15.75~53.55) |
Ⅳ级 | 1 | 216.0 |
Ⅴ级 | 1 | 212.0 |
[1] | 文昭明. 变态反应性疾病的诊治(从婴儿到成人)[M]. 2版. 北京:中国医药科技出版社,1997:28-40,331-332. |
[2] | GOIKOETXEA M J,SANZ M L,GARCÍA B E,et al. Recommendations for the use of in vitro methods to detect specific immunoglobulin E:are they comparable?[J]. J Investig Allergol Clin Immunol,2013,23(7):448-454. |
[3] | SILVERBERG J I,SIMPSON E L.Associations of childhood eczema severity:a US population-based study[J]. Dermatitis,2014,25(3):107-114. |
[4] | 路雪艳,王德旭,蒋靖,等. 湿疹皮炎患者过敏原特异性IgE检测阳性结果的多中心研究[J]. 中华皮肤科杂志,2015,48(9):616-620. |
[5] | 陈戟,程颖. 儿童湿疹872例血清过敏原特异性IgE检测结果分析[J]. 临床皮肤科杂志, 2014,43(3):148-150. |
[6] | SANTIAGO S.Food allergies and eczema[J]. Pediatr Ann,2015,44(7):265-267. |
[7] | CHALMERS J R,HAINES R H,MITCHELL E J,et al.Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children(the BEEP trial):protocol for a randomised controlled trial[J]. Trials,2017,18(1):343. |
[8] | 郑岚,杨蔺,王星. 上海地区2 437例食物不耐受患儿过敏原谱检测分析[J]. 检验医学,2018,33(9):786-789. |
[9] | World Allergy Organization.White book on allergy[R]. 2011. |
[10] | 陈同辛,张慧. 婴幼儿牛奶蛋白过敏症的诊断和治疗指南[J]. 实用儿科临床杂志,2009,24(21):1697-1700. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||